Aytu BioPharma Inc. (AYTU)
NASDAQ · Healthcare
Aytu BioPharma Inc. Long Term Debt 2014–2025
Aytu BioPharma Inc. annual/quarterly long term debt history from 2022 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Aytu BioPharma Inc. long term debt for the quarter ending June 30, 2025 were 10.9M, a 0.17% increase year-over-year.
- Aytu BioPharma Inc. long term debt for 2025 were 10.9M, a 0.17% increase from 2024.
- Aytu BioPharma Inc. long term debt for 2024 were 10.9M, a 27.49% decrease from 2023.
- Aytu BioPharma Inc. long term debt for 2023 were 15.0M, a 0.00% increase from 2022.
- Aytu BioPharma Inc. long term debt for 2022 were 15.0M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Aytu BioPharma Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $11 |
| 2024 | $11 |
| 2023 | $15 |
| 2022 | $15 |
| Aytu BioPharma Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-06-30 | $11 |
| 2024-06-30 | $11 |
| 2023-06-30 | $15 |
| 2022-06-30 | $15 |
Aytu BioPharma Inc. Long Term Debt — FAQ
Aytu BioPharma Inc. (AYTU) long term debt over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AYTU's long term debt history?
The chart and table above show Aytu BioPharma Inc.'s long term debt by year and by quarter, including the growth rate.